One Wealth Capital Management’s Edwards Lifesciences EW Stock Holding History

One Wealth Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$422K	Buy	+4,664	New	+$391K	0.12%	128

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

One Wealth Capital Management's EW Position: Q2 2026 in Review

One Wealth Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 4,664 shares worth $422K. The stake represents 0.12% of the portfolio and ranks #128 among its holdings.

563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

One Wealth Capital Management held 4,664 shares of Edwards Lifesciences worth $422K as of Q2 2026.
Edwards Lifesciences was a new One Wealth Capital Management position in Q2 2026.
Edwards Lifesciences made up 0.12% of One Wealth Capital Management's portfolio in Q2 2026, its #128 holding.
563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on One Wealth Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.